| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $51.26M | - | |
| Other | 401.3K | $9.43M | -5,000 | |
| CFO | 256.7K | $6.04M | - | |
| Other | 230.7K | $5.42M | -105,762 | |
| Other | 113.5K | $2.67M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Robins Harlan S83 | Chief Scientific Officer | Sell | 470,266 | $13.17 | $6,193,403.22 | -12.2% | +22.1% | - | |
| Mar 11, 2026 | Robins Chad M62 | CEO And Chairman | Sell | 470,167 | $13.17 | $6,192,099.39 | -8.7% | +22.1% | - | |
| Jan 12, 2026 | Piskel Kyle | Chief Financial Officer | Sale+OE | 4,290 | $18.00 | $77,220.00 | -1.9% | -30.0% | - | |
| Jan 12, 2026 | Lo Francis78 | Chief People Officer | Sale+OE | 79,590 | $17.73 | $1,411,130.70 | -20.1% | -30.0% | - | |
| Jan 6, 2026 | Robins Harlan S83 | Chief Scientific Officer | Sell | 10,000 | $16.44 | $164,400.00 | -0.8% | -12.6% | - | |
| Jan 5, 2026 | Robins Chad M62 | CEO And Chairman | Sell | 124,998 | $15.59 | $1,948,718.82 | -4.6% | -12.9% | - | |
| Jan 2, 2026 | Lo Francis78 | Chief People Officer | Sale+OE | 3,125 | $16.08 | $50,250.00 | -1.0% | -6.9% | - | |
| Dec 22, 2025 | Lo Francis78 | Chief People Officer | Sale+OE | 4,394 | $17.50 | $76,895.00 | -1.4% | -21.5% | - | |
| Dec 15, 2025 | Lo Francis78 | Chief People Officer | Sale+OE | 113,890 | $15.57 | $1,773,267.30 | -26.5% | -15.1% | - | |
| Dec 10, 2025 | Hershberg Robert64 | Director | Sell | 22,968 | $16.00 | $367,488.00 | -33.0% | -7.8% | - |